SCHEMBL8726980

SCHEMBL8726980

O=C(NCC1(O)CCCCC1)c1cccnc1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.57
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
ROCK2 O75116 1/20 0.50
HDAC1 Q13547 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
ALDH1A1 P00352 1/20 0.49
TSHR P16473 1/20 0.49
KDM4E B2RXH2 1/20 0.49
P2RX7 Q99572 1/20 0.48
EPHX2 P34913 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
MAPT P10636 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28281220 0.82 LMNA (0.65) SMN1; SMN2ROCK2ALDH1A1P2RX7
SCHEMBL28280153 0.77 LMNA (0.62) NPC1RAB9ASMN1; SMN2ROCK2ALDH1A1
SCHEMBL3727342 0.75 TSHR (0.56) THRBMEN1KMT2AROCK2HDAC1
SCHEMBL25328235 0.75 THRB (0.77) THRBMEN1KMT2ANPC1RAB9A
SCHEMBL14415899 0.75 THRB (0.77) THRBMEN1KMT2ANPC1RAB9A
SCHEMBL30467208 0.75 LMNA (0.75) MEN1KMT2ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL21082049 0.75 KMT2A (0.52) THRBMEN1KMT2ANPC1RAB9A
SCHEMBL22639760 0.74 SMN1; SMN2 (0.51) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL27761582 0.74 TSHR (0.55) THRBNPC1RAB9ASMN1; SMN2ROCK2
SCHEMBL31716729 0.74 NAMPT (0.43) THRBROCK2P2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0335545-B2 Pharmaceutical formulations for parenteral use UNIV FLORIDA (US) 1998-09-23 EP disclosed
EP-0327766-B1 Redox systems for brain-targeted drug delivery UNIV FLORIDA (US) 1998-04-08 EP disclosed
US-5024998-A Administering in aqueous solution with cyclodextrin derivative UNIVERSITY OF FLORIDA (US) 1991-06-18 US disclosed
US-5017566-A Redox systems for brain-targeted drug delivery UNIVERSITY OF FLORIDA (US) 1991-05-21 US disclosed
US-5002935-A Inclusion Complexing Hydroxypropylcyclodextrin with a Dihydropyridine-substituted Drug UNIVERSITY OF FLORIDA (US) 1991-03-26 US disclosed
US-4983586-A Decreasing precipitation at injection site or in lungs or other organs by combining with hydroxypropyl-beta-cyclodextrin UNIVERSITY OF FLORIDA (US) 1991-01-08 US disclosed
EP-0335545-A2 Pharmaceutical formulations for parenteral use UNIVERSITY OF FLORIDA (US) 1989-10-04 EP disclosed
EP-0327766-A2 Redox systems for brain-targeted drug delivery UNIVERSITY OF FLORIDA (US) 1989-08-16 EP disclosed